PMH42 - COST-UTILITY ANALYSIS OF CARIPRAZINE COMPARED TO RISPERIDONE AMONG PATIENTS WITH NEGATIVE SYMPTOMS OF SCHIZOPHRENIA IN SELECTED NORDIC COUNTRIES
Abstract
Authors
B. Nemeth R. Bendes B. Nagy K. Corcoran F. Lelli L. Fonticoli Z. Vokó